Answer
Methyldopa probably lowers blood pressure through conversion to alpha-methylnoradrenaline, which acts mainly in the central nervous system by stimulating central inhibitory alpha-adrenergic receptors, acting as a false neurotransmitter, and/or reducing plasma renin activity.
Sources for this answer
- Methyldopa Tablets 250 mgAspen · emc · SmPC §5.1 Pharmacodynamic properties · Version 7Document updated
Sources checked